Pfizer says mid-stage trial data support monthly dosing for GLP-1 therapy
Source: SeekingAlpha
2026-06-06 10:09:29 ET
More on Pfizer
- Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript
- Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian
- Pfizer in pact with Chai Discovery to use AI platform in drug development
Read the full article on Seeking Alpha
For further details see:
Pfizer says mid-stage trial data support monthly dosing for GLP-1 therapy
Pfizer Inc.
NASDAQ: PFE
PFE Trading
-1.18% G/L:
$24.755 Last:
24,820,343 Volume:
$25.09 Open:
PFE Latest News
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
